Editas Medicine Inc (EDIT)
2.88
-0.03
(-1.03%)
USD |
NASDAQ |
Nov 04, 16:00
2.88
0.00 (0.00%)
Pre-Market: 08:51
Editas Medicine Free Cash Flow: -171.54M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -171.54M |
| March 31, 2024 | -151.03M |
| December 31, 2023 | -136.90M |
| September 30, 2023 | -156.25M |
| June 30, 2023 | -169.17M |
| March 31, 2023 | -167.60M |
| December 31, 2022 | -181.47M |
| September 30, 2022 | -176.00M |
| June 30, 2022 | -170.51M |
| March 31, 2022 | -173.69M |
| December 31, 2021 | -171.78M |
| September 30, 2021 | -175.83M |
| June 30, 2021 | -189.29M |
| March 31, 2021 | -180.33M |
| December 31, 2020 | -187.00M |
| September 30, 2020 | -106.20M |
| June 30, 2020 | -78.73M |
| March 31, 2020 | -73.35M |
| Date | Value |
|---|---|
| December 31, 2019 | -46.84M |
| September 30, 2019 | -86.26M |
| June 30, 2019 | -65.91M |
| March 31, 2019 | -56.71M |
| December 31, 2018 | -50.46M |
| September 30, 2018 | -75.73M |
| June 30, 2018 | -95.68M |
| March 31, 2018 | -104.08M |
| December 31, 2017 | -11.48M |
| September 30, 2017 | -0.471M |
| June 30, 2017 | 10.50M |
| March 31, 2017 | 25.97M |
| December 31, 2016 | -53.74M |
| September 30, 2016 | -47.80M |
| June 30, 2016 | -42.17M |
| March 31, 2016 | -11.20M |
| December 31, 2015 | -6.874M |
Free Cash Flow Range, Past 5 Years
-189.29M
Minimum
Jun 2021
-46.84M
Maximum
Dec 2019
-150.71M
Average
-170.51M
Median
Jun 2022
Free Cash Flow Benchmarks
| EyePoint Pharmaceuticals Inc | -94.36M |
| Cassava Sciences Inc | -86.31M |
| Regeneron Pharmaceuticals Inc | 3.319B |
| Vertex Pharmaceuticals Inc | -1.426B |
| Adverum Biotechnologies Inc | -89.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -57.06M |
| Cash from Investing (Quarterly) | 51.95M |
| Cash from Financing (Quarterly) | 0.322M |
| Free Cash Flow Per Share (Quarterly) | -0.7357 |
| Free Cash Flow to Equity (Quarterly) | -60.56M |
| Free Cash Flow Yield | -72.71% |